Rite Aid is chopping its annual earnings forecast three days before its shareholders vote on whether to approve the sale of the company, reported Bloomberg. Grocery store chain Albertsons announced in February a plan to buy Rite Aid’s more than 2,500 drugstores. The grocer offered either a share of its stock and US$1.83 in cash or slightly more than one Albertsons share for every 10 Rite Aid shares.
Shares of the nation’s third-largest drugstore chain tumbled 10% Monday, August 6, after the company said generic drug pricing isn’t shaping up how it expected in April when it first made its fiscal 2019 forecast. It had reaffirmed that forecast as recently as late June.
The company now expects a range of break-even to an adjusted loss of ¢4 per share. It had predicted earnings of ¢2 to ¢6 per share.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
OpenAI Board Denies Receiving Formal Bid from Elon Musk
Feb 12, 2025 by
CPI
Thomas Kauper, Former DOJ Antitrust Leader, Dies at 89
Feb 12, 2025 by
CPI
BlackRock’s Acquisition of Preqin Secures UK Regulatory Approval
Feb 12, 2025 by
CPI
NFL Sued Over Bluesky Ban by Fans Citing Antitrust Violations
Feb 12, 2025 by
CPI
Warburg Pincus Strikes $1 Billion Deal to Acquire Vermont Information Processing
Feb 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon